Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rossmax InternationalROCO:4121 60 Buyback Yield % is 3.80 as of Jul. 23, 2026, which is 414% above its 10-year median of 0.74. GuruFocus rates ROCO:4121 with a GF Score™ of 60/100 and a GF Value™ of NT$19.01 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 348 Medical Devices & Instruments companies, Rossmax International ranks better than 93.97% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Rossmax International Buyback Yield % Related Terms
Rossmax International Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Rossmax International's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4121 vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Rossmax International's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossmax International Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rossmax International's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Rossmax International's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossmax International (ROCO:4121) has a Buyback Yield % of 3.80 as of Jul. 23, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Rossmax International and its competitors. This is 414% above median its historical median of 0.74. According to the industry distribution chart, Rossmax International ranks #21 out of 348 companies in the Medical Devices & Instruments industry, placing it in the top 6%.
Is Rossmax International's Buyback Yield % too high?
Rossmax International's current Buyback Yield % of 3.80 is 414% above median its 10-year median of 0.74. Based on the distribution chart, Rossmax International ranks #21 out of 348 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Rossmax International has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossmax International's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rossmax International ranks #21 out of 348 companies for Buyback Yield %. This places Rossmax International in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Rossmax International and its competitors. Rossmax International's current Buyback Yield % is 3.80, which is 414% above median its own 10-year median of 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossmax International stock overvalued right now?
Based on GuruFocus' analysis, Rossmax International (ROCO:4121) is currently considered Possible Value Trap. The stock's GF Value™ is NT$19.01, compared to a current price of NT$13.30 — trading 30% below its estimated fair value. The current Buyback Yield % is 3.80, which is 414% above median its 10-year median of 0.74. Rossmax International's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Rossmax International (ROCO:4121), the current Buyback Yield % is 3.80 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossmax International (ROCO:4121) Overvalued in 2026?
Based on GuruFocus' analysis, Rossmax International stock appears to be undervalued.
The current stock price of NT$13.30 is trading 30% below its estimated GF Value™ of NT$19.01.
GuruFocus considers Rossmax International to be Possible Value Trap.
Key valuation signals for ROCO:4121:
Buyback Yield %: 3.80 (414% above median its 10-year median of 0.74)
GF Value™: NT$19.01 vs. price of NT$13.30 (30% below fair value)
No single metric tells the full story. See the ROCO:4121 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossmax International Ltd is mainly engaged in medical equipment manufacturing, wholesale or retail, and the medicine and cosmetics channels. The group has three reportable departments: the medical device department, the retail channel department, and the investment department. The medical device department manufactures various types of medical supplies. The retail channel department is engaged in the retail of cosmetics, medical equipment, food products, and beverages. Geographically, it derives key revenue from the Taiwan region and the rest from Iraq, Algeria, the U.S.A, the U.A.E, Malaysia, Iran, Kazakhstan, South Korea, Norway, Croatia, Tunisia, and Other.
60GF Score
Get the complete analysis for ROCO:4121
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4121 has been successfully added to your 
